Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Jun-23 4:06 PM View:  | G1 Therapeutics, Inc. (GTHX) | 15-Jun-23 | Grant | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
| 24-Jun-22 4:51 PM View: | G1 Therapeutics, Inc. (GTHX) | 23-Jun-22 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 07-May-21 4:15 PM View: | Gw Pharmaceuticals Plc (GWPH) | 05-May-21 | Disposition | 10,584 | -- | -- | (100%) 10.58K to 0 | |
| 02-Mar-21 9:43 PM View: | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Payment of Exercise | 1,260 | $17.85 | $22,491.00 | (11%) 11.84K to 10.58K | |
| 02-Mar-21 9:43 PM View: | Gw Pharmaceuticals Plc (GWPH) | 01-Mar-21 | Option Exercise | 3,144 | $0.00 | $4.40 | 36% 8.7K to 11.84K | |
| 06-Jan-21 9:31 PM View: | Gw Pharmaceuticals Plc (GWPH) | 04-Jan-21 | Payment of Exercise | 1,440 | $9.62 | $13,852.80 | (14%) 10.14K to 8.7K | |
| 06-Jan-21 9:31 PM View: | Gw Pharmaceuticals Plc (GWPH) | 04-Jan-21 | Option Exercise | 3,576 | $0.00 | $5.01 | 54% 6.56K to 10.14K | |
| 04-Mar-20 6:02 PM View: | Gw Pharmaceuticals Plc (GWPH) | 02-Mar-20 | Sale | 1,296 | $8.34 | $10,808.60 | (7%) 17.74K to 16.44K | |
| 07-Jan-20 5:01 PM View: | Gw Pharmaceuticals Plc (GWPH) | 03-Jan-20 | Sale | 1,536 | $8.53 | $13,102.10 | (8%) 19.27K to 17.74K | |
| 12-Apr-19 5:30 PM View: | Gw Pharmaceuticals Plc (GWPH) | 13-Mar-19 | Sale | 900 | $14.20 | $12,780.00 | (4%) 20.17K to 19.27K | |
| 15-Mar-19 9:23 PM View: | Gw Pharmaceuticals Plc (GWPH) | 03-Jan-19 | Option Exercise | 3,580 | $0.00 | $4.65 | 22% 16.59K to 20.17K | |
| 15-Aug-18 4:18 PM View: | Columbia Laboratories Inc. (JNP) | 14-Aug-18 | Disposition | 103,855 | $11.50 | $1,194,330.00 | (100%) 103.86K to 0 | 0% |
| 06-Mar-18 4:58 PM View: | Columbia Laboratories Inc. (JNP) | 03-Mar-18 | Payment of Exercise | 1,870 | $8.80 | $16,456.00 | (2%) 88.22K to 86.36K | (31%) |
| 13-Feb-18 4:12 PM View: | Columbia Laboratories Inc. (JNP) | 09-Feb-18 | Grant | 50,500 | -- | -- | 134% 37.73K to 88.22K | |
| 09-Feb-18 7:46 PM View: | Columbia Laboratories Inc. (JNP) | 07-Feb-18 | Grant | 10,000 | -- | -- | 32% 31.2K to 41.2K | |
| 09-Feb-18 7:46 PM View: | Columbia Laboratories Inc. (JNP) | 07-Feb-18 | Payment of Exercise | 3,475 | $8.40 | $29,190.00 | (8%) 41.2K to 37.73K | (37%) |
| 07-Mar-17 4:47 PM View: | Columbia Laboratories Inc. (JNP) | 03-Mar-17 | Grant | 26,200 | -- | -- | 524% 5.0K to 31.2K | |
| 29-Aug-16 2:57 PM View: | Columbia Laboratories Inc. (JNP) | 25-Aug-16 | Market Purchase | 5,000 | $5.75 | $28,750.00 | 100% 0 to 5.0K | 100% |
| 21-Sep-15 9:00 PM View: | Larimar Therapeutics, Inc. (LRMR) | 17-Sep-15 | Option Exercise | 25,000 | $9.67 | $241,750.00 | 476% 5.26K to 30.26K | |
| 21-Sep-15 9:00 PM View: | Larimar Therapeutics, Inc. (LRMR) | 17-Sep-15 | Market Option Sale (Planned) | 25,000 | $41.05 | $1,026,250.00 | (83%) 30.26K to 5.26K | 70% |
| 21-Sep-15 9:00 PM View: | Larimar Therapeutics, Inc. (LRMR) | 17-Sep-15 | Market Sale (Planned) | 1,256 | $41.05 | $51,558.80 | (24%) 5.26K to 4.0K | 70% |
| 23-Jun-14 5:52 PM View: | Larimar Therapeutics, Inc. (LRMR) | 19-Jun-14 | Purchase | 4,000 | $20.00 | $80,000.00 | 100% 0 to 4.0K |